Cargando…

Conditional survival analysis of four treatment strategies for patients with stage I non-small cell lung cancer

Conditional survival (CS) is used to describe dynamic survival possibility, taking account of the change in the survival risk that occurs with longevity. The present study aimed to explore the CS of four treatment strategies for stage I non-small cell lung cancer (NSCLC), staged according to the eig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Yicheng, Fan, Xiaoxi, Bai, Yunpeng, Huang, Dejian, Yang, Chunlu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607325/ https://www.ncbi.nlm.nih.gov/pubmed/31423169 http://dx.doi.org/10.3892/ol.2019.10413

Ejemplares similares

Conditional survival rate estimates of lobectomy, segmentectomy and wedge resection for stage IA1 non-small cell lung cancer: A population-based study
por: Fan, Xiaoxi, et al.
Publicado: (2020)

The upregulation of TMPRSS4, partly ascribed to the downregulation of miR-125a-5p, promotes the growth of human lung adenocarcinoma via the NF-κB signaling pathway
por: Fan, Xiaoxi, et al.
Publicado: (2018)

miR-373-3p promotes lung adenocarcinoma cell proliferation via APP
por: Fan, Xiaoxi, et al.
Publicado: (2018)

Effect of body mass index on survival of patients with stage I non-small cell lung cancer
por: Xie, Hao-Jun, et al.
Publicado: (2017)

A Gene Expression Signature Predicts Survival of Patients with Stage I Non-Small Cell Lung Cancer
por: Lu, Yan, et al.
Publicado: (2006)

Survival Outcomes for Patients with Surgical and Non-Surgical Treatments in Stages I-III Small-Cell Lung Cancer
por: Che, Keying, et al.
Publicado: (2018)

Establishment and Validation of a Predictive Nomogram for Postoperative Survival of Stage I Non-Small Cell Lung Cancer
por: Wang, Zhi-Hui, et al.
Publicado: (2022)

Clinicopathological variables influencing overall survival, recurrence and post-recurrence survival in resected stage I non-small-cell lung cancer
por: Wang, Chengdi, et al.
Publicado: (2020)

Optimal treatment strategies for stage I non-small cell lung cancer in veterans with pulmonary and cardiac comorbidities
por: Sigel, Keith, et al.
Publicado: (2021)

Impact of visceral pleural invasion on the association of extent of lymphadenectomy and survival in stage I non‐small cell lung cancer
por: Wo, Yang, et al.
Publicado: (2019)

Location of stage I–III non‐small cell lung cancer and survival rate: Systematic review and meta‐analysis
por: Lee, Hyun Woo, et al.
Publicado: (2018)

Impact of Lifestyle Diseases on Postoperative Complications and Survival in Elderly Patients with Stage I Non-Small Cell Lung Cancer
por: Jeong, Sang Seok, et al.
Publicado: (2017)

Survival Following Segmentectomy or Lobectomy in Patients With Stage IB Non-small-cell Lung Cancer
por: Hao, Bo, et al.
Publicado: (2020)

Interstitial lung abnormalities in patients with stage I non-small cell lung cancer are associated with shorter overall survival: the Boston lung cancer study
por: Hida, Tomoyuki, et al.
Publicado: (2021)

Development and validation of nomogram for predicting survival of elderly patients with stage I small-cell lung cancer
por: Yang, Yaji, et al.
Publicado: (2021)

Dosimetric comparison of four radiotherapy techniques for stage III non‑small cell lung cancer
por: Li, Chao, et al.
Publicado: (2023)

Hypofractionated radiotherapy for medically inoperable stage I non‐small cell lung cancer
por: Jiang, Wei, et al.
Publicado: (2015)

Survival rates of patients with tumors originating in different segments of the left upper lung in stage I to III non-small cell lung cancer
por: Xiao, Yi, et al.
Publicado: (2021)

Overexpression of S100A13 protein is associated with tumor angiogenesis and poor survival in patients with early‐stage non‐small cell lung cancer
por: Miao, Shuncheng, et al.
Publicado: (2018)

Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer
por: Chang, Joe Y, et al.
Publicado: (2012)

Pretreatment Neutrophil to Lymphocyte Ratio Is Associated with Poor Survival in Patients with Stage I-III Non-Small Cell Lung Cancer
por: Wang, Jun, et al.
Publicado: (2016)

Prognostic factors for long‐term survival following complete resection by lobectomy in stage I non‐small cell lung cancer
por: Galata, Christian, et al.
Publicado: (2022)

Tumor necrosis targeted radiotherapy of non-small cell lung cancer using radioiodinated protohypericin in a mouse model
por: Liu, Xuejiao, et al.
Publicado: (2015)

Effects of thoracic radiotherapy timing and duration on progression‐free survival in limited‐stage small cell lung cancer
por: Zhao, Shen, et al.
Publicado: (2018)

Distant Metastasis and Survival Outcomes after Computed Tomography-Guided Needle Biopsy in Resected Stage I-III Non-Small Cell Lung Cancer
por: Xi, Yuhui, et al.
Publicado: (2017)

Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non‐small cell lung cancer
por: Zhang, Pei, et al.
Publicado: (2020)

Survival outcomes for patients with four treatments in stages I–III esophageal squamous cell carcinoma: a SEER analysis
por: Wu, Jingyang, et al.
Publicado: (2021)

Surgery is a promising strategy for improving overall survival for stage III-N2 non-small cell lung cancer patients
por: Yang, Jie, et al.
Publicado: (2023)

Identification of four differentially methylated genes as prognostic signatures for stage I lung adenocarcinoma
por: Luo, Wei-Ming, et al.
Publicado: (2018)

Survival Differences by Comorbidity Burden among Patients with Stage I/II Non-Small-Cell Lung Cancer after Thoracoscopic Resection
por: Wheeler, Meghann, et al.
Publicado: (2023)

Stereotactic Radiotherapy for Stage I Small Cell Lung Cancer
por: Verma, Vivek, et al.
Publicado: (2016)

Impact of socioeconomic status on cancer staging, survival in non-small cell lung cancer
por: Yang, Xianghui, et al.
Publicado: (2022)

Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases
por: Fritz, Peter, et al.
Publicado: (2006)

Heterogeneous prognosis and adjuvant chemotherapy in pathological stage I non-small cell lung cancer patients
por: Liu, Chia-Hsin, et al.
Publicado: (2015)

Wedge Resection and Segmentectomy in Patients with Stage I Non-Small Cell Lung Carcinoma
por: Reveliotis, Konstantinos, et al.
Publicado: (2014)

Recurrence Risk Factors Analysis for Stage I Non-small Cell Lung Cancer
por: Wu, Ching-Feng, et al.
Publicado: (2015)

Serum lipidome screening in patients with stage I non-small cell lung cancer
por: Klupczynska, Agnieszka, et al.
Publicado: (2019)

Gene-Expression Signature Predicts Postoperative Recurrence in Stage I Non-Small Cell Lung Cancer Patients
por: Lu, Yan, et al.
Publicado: (2012)

The postoperative neutrophil-to-lymphocyte ratio and changes in this ratio predict survival after the complete resection of stage I non-small cell lung cancer
por: Jin, Feng, et al.
Publicado: (2016)

Change in treatment modality and trends in survival among stage I non-small cell lung cancer patients: a population-based study
por: Akhtar-Danesh, Gileh-Gol, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m5ri6bob8ij6jihpi6objpufin